News 06 Mag 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 29 Set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Actualités 29 Set 2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
Actualités 08 Mar 2023 Oculis fait son entrée au Nasdaq avec un pipeline prometteur en ophtalmologie Oculis Holding AG, une société biopharmaceutique internationale dont l’objectif est de préserver la vue et d’améliorer les soins oculaires, a ann...
News 08 Mar 2023 Oculis lists on Nasdaq with strong clinical-stage pipeline in ophthalmology Oculis Holding AG, a global biopharmaceutical company focused on saving sight and improving eye care, has announced its listing on the Nasdaq sto...
News 18 Gen 2023 Calciscon enters Eurostars project to improve patient care worldwide Calciscon, together with Amsterdam University Medical Centers and ADMESY, have signed a collaborative agreement for the development of a laborato...
Actualités 01 Feb 2022 Merck rachète la société biopharmaceutique genevoise Chord Therapeutics Chord Therapeutics, société biopharmaceutique de phase clinique qui développe des médicaments pour des maladies neuroinflammatoires rares, est ra...
News 01 Feb 2022 Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics Chord Therapeutics, a clinical stage biopharmaceutical company developing drugs for rare neuroinflammatory diseases, is being acquired by Merck.